Sponsored
Recent Updates
- Electronic Pill Market Size Estimation, Future Insights, Share Analysis, Growth Statistics and Analysis By 2030Electronic Pill Market Highlights The Electronic Pill Market is anticipated to reach USD 1.00 Billion by 2030 at 6.60% CAGR during the forecast period 2022-2030. The growing prevalence of gastrointestinal diseases, increasing unhealthy food consumption, increase in research and development activities, growing government reimbursement policies, rising geriatric population, increased need for...0 Comments 0 Shares 381 Views 0 ReviewsPlease log in to like, share and comment!
- Computer Vision in Healthcare Market by Key Players, Regions, Company Profile, Growth Opportunity, and Challenges by 2030Computer Vision in Healthcare Market Highlights According to MRFR analysis, the Computer Vision in Healthcare Market is anticipated to grow at a significant rate of 45.20%. Furthermore, the market value is further evaluated to increase up to USD 575.4 Million in the studied forecast period 2022-2030. Computer vision is utilized in diagnosis of various diseases and surgeries. Computer vision...0 Comments 0 Shares 415 Views 0 Reviews
- Computer Vision in Healthcare Market by Key Players, Regions, Company Profile, Growth Opportunity, and Challenges by 2030Computer Vision in Healthcare Market Highlights According to MRFR analysis, the Computer Vision in Healthcare Market is anticipated to grow at a significant rate of 45.20%. Furthermore, the market value is further evaluated to increase up to USD 575.4 Million in the studied forecast period 2022-2030. Computer vision is utilized in diagnosis of various diseases and surgeries. Computer vision...0 Comments 0 Shares 447 Views 0 Reviews
- Insulin Biosimilars Market | Analysis, Size, Growth, Key Players, Segmentation and Forecast By 2030Insulin Biosimilars Market Highlights A disease in which the body’s ability to produce or respond to the hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood is termed diabetes. Biosimilar insulin is designed to be highly like the original, or reference, insulin product described in a patent. As patents for major...0 Comments 0 Shares 400 Views 0 Reviews
More Stories